Specialty Pharmacy

Overall survival rate nearly doubles in patients who used aspirin post-diagnosis.

Addition of midostaurin to chemotherapy shows promise in patients with AML.

Successful response to hepatitis C treatment shows a 30 percent increased reduction in liver stiffness.

Majority of hemophilia patients show problems with mobility, daily activities, and pain.

Normal growth in lung function in early adulthood an important factor in terms of future COPD risk.

Experts provide unique perspectives on the safety, efficacy, and potential for clinical integration of 3 recently approved agents for multiple myeloma.

Rare disease can cause serious liver and cardiovascular conditions.

Addition of bortezomib to lenalidomide and low-dose dexamethasone therapy extends disease control.

Researchers determine how the liver is able to naturally inhibit HCV infection.

Scientists discover threat from AAV2 virus and from correlation to the development of liver cancer.

Recent case reports indicate possible anti-lymphoma efficacy of direct-acting antivirals in patients with both lymphoma and hepatitis C.

Anemia caused by chemotherapy for lymphoid malignancies improved in patients with non-Hodgkin's lymphoma and multiple myeloma.

Warnings about the risk of ketoacidosis and serious urinary tract infections have been added to the labels of SGLT2 inhibitors.

Potentially game changing drug may alter diabetes disease course.

David Lassen, chief clinical officer at Prime Therapeutics, discusses implications for specialty pharmacy from health care reform.

Recent case reports indicate possible anti-lymphoma efficacy of direct-acting antivirals in patients with both lymphoma and hepatitis C.

Researchers perform deeper analysis of recombinant factor VIII Fc fusion protein.

Epoetin alfa biosimilar shows promise in early study.

Pollutants may accelerate fibrosis, metabolic disease, and liver cancer.

Treatment with bevacizumab and lomustine not found to offer a survival advantage.

Top recent news in cancer drug development.

NS3 enzyme interacts with RNA and helps the pathogen replication process.

Chemosensitivity, treatment variations, and socioeconomic factors may be a significant factor.

Excess production of tumor necrosis factor causes both RA and the onset of heart valve disease.

Depression and smoking status may be valuable targets for interventions from care providers.

Engineered antibody treatment imitates functioning factor VIII to make blood clot properly.

Catch up with any news you missed this week on Specialty Pharmacy Times.

Psychosis and hepatic fibrosis associated with earlier mortality.

Processed and red meat products like bacon and salami previously deemed carcinogenic to humans.

Legislators focus on the pricing of sofosbuvir and Harvoni.